Drug	Gene	Type	Source
Dihydroergotamine mesylate	DRD2	Text_Mining(Agonist)	TTD
Dihydroergotamine mesylate	DRD2	Text_Mining(Drug(s))	TTD
Dihydroergotamine mesylate	AR	Ratio Potency (uM)=9.52052(uM)	D4 PubChem
Dihydroergotamine mesylate	DRD1	Potency=0.082(uM)	D4 PubChem
Dihydroergotamine mesylate	DRD1	Potency=8.9125(uM)	D4 PubChem
Dihydroergotamine mesylate	DRD1	Potency=8912.5(nM)	D4 ChEMBL
Dihydroergotamine mesylate	DRD1	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	DRD3	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	FASN	IC50=9.27(uM)	D4 PubChem
Dihydroergotamine mesylate	FASN	IC50=15.6(uM)	D4 PubChem
Dihydroergotamine mesylate	FASN	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	HTR1B	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	HTR1D	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	HTR1E	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	HTR1F	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	HTR5A	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	HTR7	None=None(uM)	D4 PubChem
Dihydroergotamine mesylate	MAPT	Potency=3981.1(nM)	D4 ChEMBL
Dihydroergotamine mesylate	MAPT	Potency=3162.3(nM)	D4 ChEMBL
Dihydroergotamine mesylate	TDP1	Potency=18.3564(uM)	D4 PubChem